March 14, 2025 · Form 4 insider transaction
Claypoole Robert E bought 134,000 shares of Bioventus Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 368 days after the transaction.
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.; The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date.